Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Enrolling By Invitation1
Unknown1

Clinical Trials (2)

Showing 2 of 2 trials
NCT05915260Enrolling By Invitation

CMR in T2DM: The NSR Cohort

NCT03096678Unknown

Prognosis of Patients With Compete Left Bundle Branch Block

Showing all 2 trials

Research Network

Activity Timeline